Successful treatment of invasive fusarium verticillioides infection with posaconazole in a man with acute myelogenous leukemia
Infectious Diseases in Clinical Practice, ISSN: 1056-9103, Vol: 18, Issue: 1, Page: 71-74
2010
- 2Citations
- 2Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Infections caused by Fusarium species are now the second most commonly reported mold infections in immunocompromised patients after Aspergillus species. Disseminated Fusarium infections occur most frequently in patients with hematologic malignancies and are associated with unacceptably high mortality rates. Optimal therapy is not well defined, especially in the setting of refractory neutropenia. Although polyenes are still considered the drugs of choice, they have relatively poor in vitro and in vivo efficacy. We report a case of invasive Fusarium verticillioides of the nasal septum in a gentleman with acute myelogenous leukemia who was successfully treated with posaconazole and review the literature regarding therapeutic options. © 2010 by Lippincott Williams & Wilkins.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=76149122902&origin=inward; http://dx.doi.org/10.1097/ipc.0b013e3181b21a01; http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019048-201001000-00018; https://journals.lww.com/00019048-201001000-00018; http://journals.lww.com/00019048-201001000-00018; https://dx.doi.org/10.1097/ipc.0b013e3181b21a01; https://insights.ovid.com/crossref?an=00019048-201001000-00018
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know